Home / Infliximab / Austria
AT ATC L04AB02 · updated 2 Nov 2026
Infliximab shortage in Austria
Is there an Infliximab shortage in Austria?
Yes. As of 2 Nov 2026, 4 Infliximab products are reported short in Austria, the first since 28 Sep 2026. The company estimate for the return is 31 Mar 2027. Main reason: increased demand.
Also short in Belgium. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Remsima 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, 1 Stück limited | Celltrion Healthcare Hungary Ltd. | 28 Sep 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Remsima 120 mg Injektionslösung im Fertigpen, 2 Stück limited | Celltrion Healthcare Hungary Ltd. | 12 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Remsima 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, 2 Stück limited | Celltrion Healthcare Hungary Ltd. | 14 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Remsima 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, 3 Stück limited | Celltrion Healthcare Hungary Ltd. | 14 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).